Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMounjaro can cause bruising, but the legs are not a licensed injection site — so leg bruising is usually a sign of injection technique, not the medicine itself. Most bruising associated with Mounjaro happens at the injection site (abdomen, thigh, or upper arm) and settles quickly as technique improves. Mounjaro is a prescription-only medicine; a clinician assesses whether it is right for you before any treatment begins. If you notice bruising on your legs without an obvious cause, or bruising that is spreading or unexplained, that warrants a conversation with your prescriber rather than a self-diagnosis.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
A common worry (and a frequent search) is that tirzepatide causes widespread, easy bruising across the whole body, particularly the legs. The medicine itself does not thin your blood or impair your clotting system in a way that would produce spontaneous bruises across uninjected areas. What the clinical data and the NHS patient information for tirzepatide do confirm is that injection-site reactions, including bruising, redness and mild swelling, are among the common side effects. "Common" in medicine means affecting between one in ten and one in hundred people. That is a meaningful number, but it is localised, at the site of the injection, not spread across the body.
If you inject into your thigh (which is licensed), you may well see a small bruise there, which is a very different concern from the broader question of how Mounjaro affects the legs. The distinction matters because the two situations call for different responses.
A subcutaneous injection passes a needle through skin into the fatty tissue beneath. Small capillaries run through that layer, and occasionally the needle nicks one. The result is a bruise, usually no larger than a 10p coin, fading over three to seven days. A few factors make it more likely: injecting too quickly, not letting the injection site warm to room temperature first, reusing the same spot repeatedly, or pressing too hard on the skin immediately after.
Rotation is the single most effective habit. The abdomen, outer thigh, and upper arm are all licensed sites for Mounjaro; moving systematically between them (and within each site, shifting a few centimetres each week) gives each area time to recover fully. Keeping the pen at room temperature for around 30 minutes before injecting can also reduce discomfort and localised reaction. For a thorough look at why bruising at the site occurs and how to minimise it, our guide to Mounjaro bruising goes into technique in detail.
One practical note: if your injection day tends to fall on a Monday after a busy weekend away, or just before a holiday when you are rushed, those are exactly the moments where technique slips. Taking an extra minute to settle and prepare makes a difference.
If you are seeing bruises on your lower legs (the shin, calf, or ankle) and you have not injected there, Mounjaro is almost certainly not the direct cause. Unexplained bruising on the legs can have several unrelated origins: minor trauma you did not notice, blood-thinning medications taken for other conditions, nutritional deficiencies, or, less commonly, conditions affecting platelet function or blood-vessel fragility. These are worth investigating separately.
There is one indirect pathway worth knowing about. Significant, rapid weight loss (which tirzepatide can produce) occasionally changes how the skin and underlying tissue sit, making minor knocks more visible. This is not bruising caused by the drug; it is a change in body composition affecting how bumps show up. If you are unsure whether bruising is linked to your treatment, understanding whether and how Mounjaro can cause bruising can help you work out what to look for before speaking to your prescriber.
The MHRA's Yellow Card scheme allows patients to report suspected side effects directly to the UK regulator, including any skin reactions or unusual bruising patterns. It is genuinely useful data for ongoing medicine safety monitoring, and anyone on Mounjaro can submit a report. If you notice bruising from Mounjaro that is severe, rapidly worsening, or accompanied by other unusual symptoms, contact your prescriber or GP that day rather than waiting for the next scheduled review.
Rather than deciding whether a bruise is "from Mounjaro" or not, the more useful habit is to note its location, size, and how quickly it appeared relative to your injection day. Your prescriber can then make an informed judgement. If you are currently on treatment and have concerns, the aftercare team at nume is available seven days a week, sorry, at nume, support runs seven days a week and no question is too small to raise.
For those still weighing up whether tirzepatide is the right option, it helps to understand the full side-effect picture. The tirzepatide overview covers the broader evidence base, while the Mounjaro page focuses on the UK-specific licence, dosing schedule, and what to expect during treatment. Mounjaro is a prescription medicine, and a prescriber reviews your full medical history before recommending it, including any medications that might affect bruising risk. If you are ready to start that process, you can speak to our prescribers through a free consultation.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.